ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cancer

Anti-TNF Agents May Improve Clinical Symptoms of Ankylosing Spondylitis

Lara C. Pullen, PhD  |  May 21, 2015

Ankylosing spondylitis primarily affects the joints and ligaments of the spine, but may also have an impact on other joints. Patients experience pain and stiffness that limit mobility in the back and other affected joints. Symptoms can come and go, last for long periods of time and be severe. Anti-tumor necrosis factor (anti-TNF) drugs are…

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesOther Rheumatic ConditionsResearch Rheum Tagged with:Ankylosing Spondylitisanti-tumor necrosis factorDrugsinflammationpatient careResearchtherapy

Rheumatologists on the Move

Ann-Marie Lindstrom  |  May 15, 2015

Maura Daly Iversen Named Catherine Worthingham Fellow by APTA Maura Daly Iversen, PT, DPT, SD, MPH, FNAP, FAPTA, associate editor of The Rheumatologist, was recently named a Catherine Worthingham Fellow—the highest honor among the American Physical Therapy Association (APTA) membership categories. According to the award announcement, Worthingham “motivated others to make an impact within the…

Filed under:Professional TopicsProfiles Tagged with:appointmentsAwardsCareerrheumatologist

Plaquenil: From Malaria Treatment to Managing Lupus, RA

Charles Radis, DO  |  May 15, 2015

In 1984, I wrote my first prescription for the antimalarial drug, hydroxychloroquine (Plaquenil), for a 28-year-old woman with SLE. She was considerably overweight, with inflammatory arthritis and a photosensitive rash, and I worried that oral corticosteroids would tip her over into diabetes. I presented the case to my attending, Steven Malawista, MD, at the Yale…

Filed under:ConditionsDrug UpdatesRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:drugLupusPlaquenilRheumatoid arthritis

2014 ACR/ARHP Annual Meeting: Super Proteins Eyed in Therapies for Rheumatic Diseases

Susan Bernstein  |  April 1, 2015

Immunoglobulin superfamily of proteins, CTLA-4 and PD-1, may generate treatments for RA, SLE

Filed under:Meeting ReportsResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ACR/ARHP Annual MeetingBernsteinimmunoglobulinproteinResearchRheumatic DiseaseRheumatoid arthritisSystemic lupus erythematosusTreatment

2014 ACR/ARHP Annual Meeting: Regulatory T Cells

Mary Beth Nierengarten  |  April 1, 2015

Rheumatology experts explore ways Treg cells contribute to autoimmune diseases, RA

Filed under:ConditionsMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:ACR/ARHP Annual MeetingAutoimmune diseaseNierengartenregulatory T cellsResearchRheumatoid arthritis

The ACR Recommends Cautious Approach as Biosimilars Enter U.S. Market

Richard Quinn  |  March 17, 2015

With the U.S. FDA’s first approval of a biosimilar drug earlier this month, rheumatologists stress the need to ensure safety, efficacy of such drugs in treating rheumatic diseases

Filed under:Practice Support Tagged with:ACR/ARHPBiosimilarsDrugsFDApatient safetyrheumatologistTreatment

Certolizumab Pegol Drug Studies Find No New Safety Issues

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2015

Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information

Filed under:Drug Updates Tagged with:Certolizumab PegolclazakizumabdrugFDAhydrocodone bitartrateKaufmanrheumatologySafety

Skin Disease in Rheumatology Patients Should Prompt Collaboration with Dermatologists

Vanessa Caceres  |  March 1, 2015

Patients with conditions that don’t resolve with topical steroids are signal for referral

Filed under:ConditionsPractice Support Tagged with:Dermatologyrheumatologistskin diseaseSteroidTreatment

UNC’s Thurston Arthritis Research Center in the Spotlight

Gretchen Henkel  |  February 1, 2015

Approachability, collaboration foster excellence in this basic science, clinical and epidemiological research program

Filed under:Profiles Tagged with:Henkelrheumatology

2014 ACR/ARHP Annual Meeting: Lupus Nephritis

Mary Beth Nierengarten  |  February 1, 2015

Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)drugLupus nephritis

  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 85
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences